Stavudine

Zerit - Cap 30MG

30 MG CapsuleCanadaCancelledAuthorised 30 Jul 1996

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Stavudine

Zerit - Cap 30MG

30 MG CapsuleCanadaCancelledAuthorised 30 Jul 1996

Open in the registerAsk Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Zerit

United States · 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** … · capsule · Bristol

Zerit XRUnited States · 100MG, 37.5MG, 50MG … · capsule, extended release · Bristol Myers Squibb

ZeritUnited States · 1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · for solution · Bristol

AnyNew Zealand · Cap 40 mg

AnyNew Zealand · Powder for oral soln 1 mg per ml

Documents

The official texts, at the regulator.

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Stavudine
Strength: 30 MG
Dosage form: Capsule
Route: Oral
Register: Canada (Health Canada)
Status: Cancelled
Status in the register: Cancelled Post Market
Authorised: 30 Jul 1996
Registration: DIN 02216108
Marketing authorisation holder: Bristol-Myers Squibb Canada
ATC code: J05AF04
Group: Anti-infectives for systemic use
Supply: PRESCRIPTION

Zerit - Cap 20MGStavudine · 20 MG · CapsuleCanadaCancelled

Zerit - Cap 40MGStavudine · 40 MG · CapsuleCanadaCancelled